Literature DB >> 25804906

Loss of ADAM17 is associated with severe multiorgan dysfunction.

Robert H J Bandsma1, Harry van Goor2, Michael Yourshaw3, Rudolf K Horlings4, Marcel F Jonkman4, Elisabeth H Schölvinck5, Arend Karrenbeld2, Rene Scheenstra6, Martin Kömhoff7, Patrick Rump8, Yvonne Koopman-Keemink9, Stanley F Nelson3, Johanna C Escher10, Ernest Cutz11, Martín G Martín3.   

Abstract

ADAM metallopeptidase domain 17 (ADAM17) is responsible for processing large numbers of proteins. Recently, 1 family involving 2 patients with a homozygous mutation in ADAM17 were described, presenting with skin lesions and diarrhea. In this report, we describe a second family confirming the existence of this syndrome. The proband presented with severe diarrhea, skin rash, and recurrent sepsis, eventually leading to her death at the age of 10 months. We performed exome sequencing and detailed pathological and immunological investigations. We identified a novel homozygous frameshift mutation in ADAM17 (NM_003183.4:c.308dupA) leading to a premature stop codon. CD4(+) and CD8(+) T-cell stimulation assays showed severely diminished tumor necrosis factor-α and interleukin-2 production. Skin biopsies indicated a focal neutrophilic infiltrate and spongiotic dermatitis. Interestingly, the patient developed unexplained systolic hypertension and nonspecific hepatitis with apoptosis. This report provides evidence for an important role of ADAM17 in human immunological response and underscores its multiorgan involvement.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADAM17; Congenital enteropathy; Exome sequencing; Immunodeficiency; Inflammation

Mesh:

Substances:

Year:  2015        PMID: 25804906      PMCID: PMC6044207          DOI: 10.1016/j.humpath.2015.02.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome.

Authors:  Pascal Descargues; Céline Deraison; Catherine Prost; Sylvie Fraitag; Juliette Mazereeuw-Hautier; Marina D'Alessio; Akemi Ishida-Yamamoto; Christine Bodemer; Giovanna Zambruno; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2006-04-20       Impact factor: 8.551

Review 2.  ADAM17: a molecular switch to control inflammation and tissue regeneration.

Authors:  Jürgen Scheller; Athena Chalaris; Christoph Garbers; Stefan Rose-John
Journal:  Trends Immunol       Date:  2011-07-13       Impact factor: 16.687

3.  Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis.

Authors:  M Los; M Van de Craen; L C Penning; H Schenk; M Westendorp; P A Baeuerle; W Dröge; P H Krammer; W Fiers; K Schulze-Osthoff
Journal:  Nature       Date:  1995-05-04       Impact factor: 49.962

4.  Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice.

Authors:  Aditya Murthy; Virginie Defamie; David S Smookler; Marco A Di Grappa; Keisuke Horiuchi; Massimo Federici; Maria Sibilia; Carl P Blobel; Rama Khokha
Journal:  J Clin Invest       Date:  2010-07-12       Impact factor: 14.808

5.  ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.

Authors:  Xiang-Jun Wang; Chang-Wei Feng; Min Li
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

Review 6.  Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis.

Authors:  Marcia L Moss; Liora Sklair-Tavron; Raphael Nudelman
Journal:  Nat Clin Pract Rheumatol       Date:  2008-04-15

7.  Inflammatory skin and bowel disease linked to ADAM17 deletion.

Authors:  Diana C Blaydon; Paolo Biancheri; Wei-Li Di; Vincent Plagnol; Rita M Cabral; Matthew A Brooke; David A van Heel; Franz Ruschendorf; Mark Toynbee; Amanda Walne; Edel A O'Toole; Joanne E Martin; Keith Lindley; Tom Vulliamy; Dominic J Abrams; Thomas T MacDonald; John I Harper; David P Kelsell
Journal:  N Engl J Med       Date:  2011-10-20       Impact factor: 91.245

8.  Fluorescent cell barcoding as a tool to assess the age-related development of intracellular cytokine production in small amounts of blood from infants.

Authors:  Jose Stam; Wayel Abdulahad; Minke G Huitema; Caroline Roozendaal; Pieter C Limburg; Margriet van Stuijvenberg; Elisabeth H Schölvinck
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

9.  Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis.

Authors:  Colin N A Palmer; Alan D Irvine; Ana Terron-Kwiatkowski; Yiwei Zhao; Haihui Liao; Simon P Lee; David R Goudie; Aileen Sandilands; Linda E Campbell; Frances J D Smith; Gráinne M O'Regan; Rosemarie M Watson; Jo E Cecil; Sherri J Bale; John G Compton; John J DiGiovanna; Philip Fleckman; Sue Lewis-Jones; Gehan Arseculeratne; Ann Sergeant; Colin S Munro; Brahim El Houate; Ken McElreavey; Liselotte B Halkjaer; Hans Bisgaard; Somnath Mukhopadhyay; W H Irwin McLean
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

10.  Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting.

Authors:  Liat Samuelov; Ofer Sarig; Robert M Harmon; Debora Rapaport; Akemi Ishida-Yamamoto; Ofer Isakov; Jennifer L Koetsier; Andrea Gat; Ilan Goldberg; Reuven Bergman; Ronen Spiegel; Ori Eytan; Shamir Geller; Sarit Peleg; Noam Shomron; Christabelle S M Goh; Neil J Wilson; Frances J D Smith; Elizabeth Pohler; Michael A Simpson; W H Irwin McLean; Alan D Irvine; Mia Horowitz; John A McGrath; Kathleen J Green; Eli Sprecher
Journal:  Nat Genet       Date:  2013-08-25       Impact factor: 38.330

View more
  14 in total

Review 1.  The ADAMs family of proteases as targets for the treatment of cancer.

Authors:  Maeve Mullooly; Patricia M McGowan; John Crown; Michael J Duffy
Journal:  Cancer Biol Ther       Date:  2016-04-26       Impact factor: 4.742

Review 2.  Advances in Evaluation of Chronic Diarrhea in Infants.

Authors:  Jay R Thiagarajah; Daniel S Kamin; Sari Acra; Jeffrey D Goldsmith; Joseph T Roland; Wayne I Lencer; Aleixo M Muise; James R Goldenring; Yaron Avitzur; Martín G Martín
Journal:  Gastroenterology       Date:  2018-04-12       Impact factor: 33.883

Review 3.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

4.  Phosphatidylserine exposure is required for ADAM17 sheddase function.

Authors:  Anselm Sommer; Felix Kordowski; Joscha Büch; Thorsten Maretzky; Astrid Evers; Jörg Andrä; Stefan Düsterhöft; Matthias Michalek; Inken Lorenzen; Prasath Somasundaram; Andreas Tholey; Frank D Sönnichsen; Karl Kunzelmann; Lena Heinbockel; Christian Nehls; Thomas Gutsmann; Joachim Grötzinger; Sucharit Bhakdi; Karina Reiss
Journal:  Nat Commun       Date:  2016-05-10       Impact factor: 14.919

Review 5.  A Disintegrin and Metalloprotease 17 in the Cardiovascular and Central Nervous Systems.

Authors:  Jiaxi Xu; Snigdha Mukerjee; Cristiane R A Silva-Alves; Alynne Carvalho-Galvão; Josiane C Cruz; Camille M Balarini; Valdir A Braga; Eric Lazartigues; Maria S França-Silva
Journal:  Front Physiol       Date:  2016-10-18       Impact factor: 4.566

6.  Loss of PACS-2 delays regeneration in DSS-induced colitis but does not affect the ApcMin model of colorectal cancer.

Authors:  Sarah L Dombernowsky; Jeanette Schwarz; Jacob Samsøe-Petersen; Reidar Albrechtsen; Kim B Jensen; Gary Thomas; Marie Kveiborg
Journal:  Oncotarget       Date:  2017-11-26

7.  The enhanced susceptibility of ADAM-17 hypomorphic mice to DSS-induced colitis is not ameliorated by loss of RIPK3, revealing an unexpected function of ADAM-17 in necroptosis.

Authors:  Johaiber Fuchslocher Chico; Maren Falk-Paulsen; Anne Luzius; Carina Saggau; Barbara Ruder; Julia Bolik; Dirk Schmidt-Arras; Andreas Linkermann; Christoph Becker; Philip Rosenstiel; Stefan Rose-John; Dieter Adam
Journal:  Oncotarget       Date:  2018-02-05

8.  Mutagenesis of the ADAM17-phosphatidylserine-binding motif leads to embryonic lethality in mice.

Authors:  Martin Veit; Björn Ahrens; Jana Seidel; Anselm Sommer; Sucharit Bhakdi; Karina Reiss
Journal:  Life Sci Alliance       Date:  2019-08-27

Review 9.  A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions.

Authors:  Nives Giebeler; Paola Zigrino
Journal:  Toxins (Basel)       Date:  2016-04-23       Impact factor: 4.546

Review 10.  Expression, Role, and Regulation of Neutrophil Fcγ Receptors.

Authors:  Yu Wang; Friederike Jönsson
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.